Professor Ekaterini Alexiou-Chatzaki discusses ABCureD’s success, at the NBG Seed Awards, with Ioannis Pantazopoulos, host of the RADIO Lifo podcast. The topic was Health & Innovation: the people behind the succesful startups.
Prof. Ekaterini Chatzaki, CEO and coFounder of ABCURED, was interviewed by Maria Moschou for the Greek online media EURO2day regarding the recent first award received at the NBG (National Bank Greece) Seed Awards, for our innovative first diabetes prediction product, LPancreas.
ABCureD and LPancreas were featured on Sunday’s BHMAgazino as first prize winners of the NBG Business Seeds 13th Innovation & Technology Competition for its groundbreaking invention in diabetes management.
Startup Ole in collaboration with EIT Health – RIS Innovation 2023, organised an event, in Salamanca during 4-7th September 2023, that brought together innovators, entrepreneurs and pioneers in the health sector.
ABCureD was the standout winner of the NBG Business Seeds 13th Innovation & Technology Competition for its groundbreaking invention in diabetes management.
ABCureD had the unique honor to win 1st place in the 3rd HBIO forum competition for its innovative diagnostic kit, LPancreas, which can diagnose pancreatic decline using liquid biobsy and ML. Dr. Akaterini Alexiou-Hatzaki, Professor of Pharmacology at the Democritus University of Thrace, was awarded the first prize on behalf of the company.
We’re very pleased to have been selected with our DIAPREPI proposal to participate in the RIS Innovation Call 2023. At ABCureD we look forward to collaborating once again with #JADBio and #Harokopio University, to bring our test for diabetes in the market!